# Jack Milwid

> Jack Milwid is a scientist-turned-company-builder who sits in the Office of the CEO at Lila Sciences, the Flagship Pioneering venture chasing 'scientific superintelligence' through autonomous AI-run laboratories. A materials engineer with a Harvard-MIT PhD, he has spent his career founding biotech companies from scratch - among them Sana Biotechnology, Neon Therapeutics, Cobalt Biomedicine and Kaleido Biosciences - and co-founded the investment firm Related Sciences. His trademark is turning early science into operating companies.

- **Role:** Office of the CEO at Lila Sciences
- **Organizations:** Lila Sciences, Related Sciences, Flagship Pioneering, Third Rock Ventures, Sana Biotechnology, Neon Therapeutics, Cobalt Biomedicine, Kaleido Biosciences
- **Nationality:** American
- **Education:** Ph.D., Medical Engineering and Medical Physics, Harvard-MIT Division of Health Sciences and Technology (MIT), M.S., Materials Science and Engineering, Massachusetts Institute of Technology, Sc.B., Metallurgical and Materials Engineering, Colorado School of Mines
- **Known for:** Co-founder of Sana Biotechnology, an engineered-cell medicines company that went public (SANA), Co-founder of Neon Therapeutics, a pioneer in personalized cancer neoantigen vaccines, Founder and R&D leader of targeted gene therapy company Cobalt Biomedicine

## Career timeline

- **2011** — Completes Ph.D. at the Harvard-MIT Division of Health Sciences and Technology
- **2010s** — Entrepreneur at Third Rock Ventures; co-founds cancer neoantigen vaccine pioneer Neon Therapeutics
- **2010s** — Principal at Flagship Pioneering; co-founds Sana Biotechnology, founds and leads R&D at Cobalt Biomedicine, becomes founding head of strategy at Kaleido Biosciences
- **2020** — Co-founds Related Sciences, serving as Partner and President
- **2025** — Joins Lila Sciences in the Office of the CEO as the company scales its autonomous AI labs

## Achievements

- Co-founder of Sana Biotechnology, an engineered-cell medicines company that went public (SANA)
- Co-founder of Neon Therapeutics, a pioneer in personalized cancer neoantigen vaccines
- Founder and R&D leader of targeted gene therapy company Cobalt Biomedicine
- Founding head of strategy for microbiome therapeutics company Kaleido Biosciences
- Co-founder, Partner and President of investment firm Related Sciences
- Earned a Ph.D. from the Harvard-MIT Division of Health Sciences and Technology

## Latest updates

- **2025-09** — Lila Sciences, where Milwid works in the Office of the CEO, announced a $235M Series A led by Braidwell and Collective Global to expand its autonomous AI research labs.
- **2025-10** — Lila closed a $350M Series A extension, bringing total capital raised to roughly $550M.

## Links

- Website: https://lila.ai
- LinkedIn: http://www.linkedin.com/in/jackmilwid

---

Profile page: https://yespress.io/jack-milwid
Published by YesPress — https://yespress.io
Last updated: 2026-07-01